Clarivate Plc (CLVT) Bundle
As a global provider of transformative intelligence, how does Clarivate Plc (CLVT) manage to be a mission-critical partner to over 50,000 customers, guiding the world's most important research and innovation? With a full-year 2025 revenue outlook of $2.42 billion to $2.45 billion and a highly sticky business model-where organic recurring revenue accounts for an impressive 88% of the total-Clarivate is a powerful, defintely undervalued force in the data analytics space. You need to understand the history of this company, which traces its roots back to the 1960s, and how its core subscription products like Web of Science and Derwent Innovation actually generate that revenue. Let's break down the ownership, the mission to advance research, and the mechanics behind their recent 93% subscription renewal rate.
Clarivate Plc (CLVT) History
You're looking for the definitive story of Clarivate Plc, and honestly, it's less a single founding moment and more a strategic carve-out of a massive information empire. The company you see today, trading as CLVT, was formally established in 2016, but its core products have a heritage stretching back to the 1960s. This isn't a startup story; it's a private equity-backed play to unlock the value of mission-critical data assets.
Clarivate Plc's Founding Timeline
Year established
Clarivate Plc was formally established on October 3, 2016, following the acquisition of the Intellectual Property and Science business of Thomson Reuters.
Original location
The company maintains dual headquarters in Philadelphia, United States, and London, United Kingdom.
Founding team members
The company was created through a strategic acquisition led by two major private equity firms: Onex Corporation and Baring Private Equity Asia.
Initial capital/funding
The initial transaction to acquire the business from Thomson Reuters was valued at approximately $3.55 billion.
Clarivate Plc's Evolution Milestones
| Year | Key Event | Significance |
|---|---|---|
| 1960s | Founding of the Institute for Scientific Information (ISI) | Established the foundational assets, including the concept of citation indexing, which underpins the Mission Statement, Vision, & Core Values of Clarivate Plc (CLVT). |
| 2016 | Acquisition by Onex and Baring Asia; Clarivate Analytics is formed | Spun off the Intellectual Property and Science division from Thomson Reuters, creating an independent, focused entity. |
| May 2019 | Merger with Churchill Capital Corp and NYSE listing (CLVT) | Became a publicly traded company, providing significant capital and liquidity for future M&A strategy. |
| Jan 2020 | Acquisition of Decision Resources Group (DRG) | Significantly expanded the Life Sciences & Healthcare segment, diversifying revenue streams. |
| Dec 2021 | Acquisition of ProQuest for $5.3 billion | A massive deal that expanded the Academia & Government segment, bringing in library software and content solutions. |
| Aug 2024 | Matti Shem Tov is appointed as new CEO | A major leadership change to drive the company's Value Creation Plan (VCP) and subscription-first strategy. |
Clarivate Plc's Transformative Moments
The company's trajectory is defined by two major transformative decisions: the 2016 carve-out and the aggressive, debt-fueled acquisition strategy that followed. You can't ignore the debt load-as of March 31, 2025, total debt stood at $4,570.8 million. That's the cost of this rapid expansion.
The transition to a public company via a Special Purpose Acquisition Company (SPAC) merger in 2019 was a key pivot, accelerating its ability to raise capital for acquisitions like the 2021 ProQuest deal. That $5.3 billion purchase was a game-changer, making Clarivate a dominant force in academic and research information.
More recently, the company's focus is on operational efficiency, reflected in the launch of its Value Creation Plan (VCP) in late 2024. This shift is defintely necessary to digest the acquisitions and drive organic growth, which was a modest 0.3% in Q1 2025. The goal is to move to a subscription-first model, which is a sound strategy given the recurring revenue nature of its core products.
- Subscription-First Focus: A strategic shift to prioritize recurring revenue, aiming for improved renewal rates and higher usage across key products.
- Life Sciences Expansion: The 2020 acquisition of Decision Resources Group (DRG) was critical, providing high-value data and analytics for the healthcare industry.
- 2025 Financial Reality: Despite the strategic plan, Q1 2025 saw a net loss of $103.9 million on revenues of $593.7 million, showing the integration and restructuring costs are still hitting the bottom line.
- Forward Outlook: Management is confident, raising the full-year 2025 revenue outlook to a range of $2.42 billion to $2.45 billion as of October 2025.
Clarivate Plc (CLVT) Ownership Structure
Clarivate Plc (CLVT) operates as a publicly traded company on the New York Stock Exchange (NYSE), but its ownership structure is heavily weighted toward institutional and private equity (PE) investors, meaning a small number of large funds control the vast majority of the shares and therefore the strategic direction.
This structure gives the company access to public capital while keeping governance largely in the hands of sophisticated, long-term financial stakeholders, a common setup for companies that have gone public via a Special Purpose Acquisition Company (SPAC) or have significant private equity backing.
Clarivate Plc's Current Status
Clarivate Plc is a publicly listed entity trading under the ticker CLVT on the NYSE. This status means the company is subject to the rigorous financial reporting and transparency rules of the U.S. Securities and Exchange Commission (SEC), providing investors with a clear view into its operations and financial health.
The company's market capitalization stood at approximately $2.32 billion as of November 13, 2025, reflecting its valuation as a key player in the professional information services sector.
Understanding the balance between public listing and concentrated ownership is defintely crucial for assessing risk and opportunity. To see how these stakeholders align with the company's long-term goals, you should look at the Mission Statement, Vision, & Core Values of Clarivate Plc (CLVT).
Clarivate Plc's Ownership Breakdown
The company's capital structure is dominated by institutional holders, which include major private equity firms that were instrumental in its formation and growth. Here's the quick math on where the control lies, based on the latest 2025 fiscal year data:
| Shareholder Type | Ownership, % | Notes |
|---|---|---|
| Major Institutional/Private Equity | 54.10% | Includes Leonard Green & Partners (17.64%), Clarkston Capital Partners (10.59%), Exor N.V. (10.17%), Onex Corp (9.20%), and Impactive Capital LP (6.50%). |
| Other Institutional Investors | 32.71% | The remaining portion of the total institutional holding of 86.81%, held by entities like BlackRock, Inc. and Dimensional Fund Advisors LP. |
| Insider/Executive | 1.3% | Shares held by non-PE-affiliated executives and directors, valued at roughly $31 million as of November 2025. |
| Retail/Other Investors | 11.89% | The remaining float of shares held by individual and smaller investors. |
What this estimate hides is the power of the major institutional holders; their combined stake gives them significant influence over board appointments and major corporate actions, effectively concentrating decision-making.
Clarivate Plc's Leadership
The company is steered by a seasoned executive team with deep expertise in software, data, and analytics, which is exactly what you want in a professional information services firm. The leadership team is responsible for translating the board's strategic vision into operational results.
The key leaders as of November 2025 are:
- Matti Shem Tov: Chief Executive Officer (CEO), appointed in August 2024. He leads the dynamic global team.
- Andrew M. Snyder: Board Chair, who provides strategic oversight and has a long history in the information services space.
- Jonathan Collins: Executive Vice President and Chief Financial Officer (CFO).
- John Doulamis: Senior Vice President, General Counsel.
- Bill Graff: Executive Vice President and Chief Information Officer (CIO).
This team is structured to manage the company's three core segments, ensuring specialized focus on each revenue stream:
- Henry Levy: President, Life Sciences & Healthcare.
- Maroun S. Mourad: President, Intellectual Property.
- Bar Veinstein: President, Academia & Government.
The CEO, Matti Shem Tov, owns approximately 0.25% of the company's shares, a holding worth about $5.78 million, aligning his personal financial interest with shareholder returns.
Clarivate Plc (CLVT) Mission and Values
Clarivate Plc's core purpose moves beyond simply selling data; its mission is to accelerate the world's pace of innovation by providing transformative intelligence and trusted partnership. This focus on advancing human ingenuity is the defintely foundation of their strategy, which is critical when you consider their projected full-year 2025 revenue outlook is between $2.42 billion and $2.45 billion.
The company's cultural DNA is woven into its values, guiding how they operate across their three main segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. They are a global provider of transformative intelligence, so their non-financial purpose is their competitive edge.
Clarivate Plc's Core Purpose
Understanding a company's mission and vision is like getting the blueprint for their long-term capital allocation strategy. It tells you where the money will go and why.
Official mission statement
The mission statement for Clarivate Plc is clear: To advance the success of people and organizations through transformative intelligence and trusted partnership. This isn't just about selling a database; it's about being an essential partner in the innovation lifecycle, from initial research to commercialization.
Here's the quick math on their recent performance: for the first quarter of 2025, Clarivate reported a net loss of $103.9 million, but they also generated $171.2 million in operating cash flow, showing a strong ability to fund their mission-critical operations despite the GAAP loss.
- Aim for greatness: Strive for excellence in all services and products.
- Value every voice: Foster a culture of mutual respect and collaboration.
- Own your actions: Maintain accountability and integrity in all business practices.
You can see how these values translate directly into their products, like the Web of Science, which is a comprehensive research database. Mission Statement, Vision, & Core Values of Clarivate Plc (CLVT).
Vision statement
The vision statement is aspirational, painting a picture of the ultimate impact Clarivate Plc wants to have on the world. It's a powerful statement of intent for a company whose full-year 2025 earnings per share (EPS) guidance is expected to be between $0.600 and $0.700.
- Fuel the world's greatest breakthroughs by harnessing the power of human ingenuity.
That's a big goal. It means their data and analytics have to be the engine behind the next major medical discovery or patent filing. That's a high bar for quality and service.
Clarivate Plc slogan/tagline
The company's mindset is captured in a simple, action-oriented phrase.
- Think forward™
They also use the phrase, 'Whatever your world, we're here to help you succeed,' which speaks to their customer-centric approach. This forward-looking stance is key to their subscription-first model, which is designed to drive organic recurring revenue growth. In Q1 2025, organic recurring revenues increased by 0.6%, showing this strategy is on track.
Clarivate Plc (CLVT) How It Works
Clarivate Plc operates as a 'transformative intelligence' provider, curating and delivering highly specialized data, analytics, and workflow solutions to accelerate the lifecycle of innovation for its customers. The company primarily makes money through a sticky, subscription-first model, which accounted for an improved 88% of its organic recurring revenue mix through the first nine months of 2025.
Clarivate Plc's Product/Service Portfolio
Clarivate's offerings are mission-critical tools across three core segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property (IP). For the first half of 2025, the company reported total revenues of $1,215.1 million.
| Product/Service | Target Market | Key Features |
|---|---|---|
| Web of Science Platform | Academic Institutions, Government Research Agencies | Premier scholarly and scientific research tools; curated content for research discovery and referencing; includes the Web of Science Core Collection. |
| Cortellis | Pharmaceutical, Biotech, and Medical Device Companies | AI-powered intelligence and analytics for drug development, clinical trials, and commercialization; extensive and specialized therapeutic area data. |
| Derwent Innovation | Corporate IP Teams, Patent Attorneys, R&D Departments | Comprehensive, trusted patent search and analysis; global patent data for competitive intelligence and IP lifecycle management. |
| ProQuest One Academic | Academic and Public Libraries | World's largest curated collection of essential content (e-books, dissertations, journals) aggregated for content discovery and acquisition. |
Clarivate Plc's Operational Framework
Clarivate's operational framework centers on its multi-year Value Creation Plan, which is designed to transition the company to a higher-margin, subscription-led business by focusing on proprietary data and AI-led product innovation. Here's the quick math: generating $160.6 million in free cash flow in the first half of 2025 shows a clear focus on cash generation and efficiency.
- Data Curation and Enrichment: Collect, normalize, and enrich vast, disparate datasets-from patent filings and clinical trials to scholarly publications-to create proprietary, structured intelligence assets.
- Subscription-First Model: Drive recurring revenue by migrating customers to subscription-based solutions (Software as a Service or SaaS) and away from less predictable transactional sales, improving the organic recurring revenue mix to 88% through Q3 2025.
- AI-Powered Workflow Integration: Rapidly deploy Agentic AI and new AI-native solutions across flagship portfolios like Web of Science, Derwent, and Cortellis to embed intelligence directly into customer workflows, enhancing product defintely differentiation.
- Operational Efficiency: Execute strategic disposals of non-core assets and implement cost efficiencies to improve the Adjusted EBITDA margin, which was 41% for the first half of 2025.
Clarivate Plc's Strategic Advantages
You're investing in a company whose core advantage is its deep, proprietary data moats and the high switching costs associated with its integrated platforms. These aren't easy to replicate, and they drive the strong renewal rates.
- Proprietary Data Assets: Own and maintain unique, historical, and highly structured datasets like the Web of Science Core Collection and Derwent World Patents Index, which are the canonical sources for research and IP evaluation.
- High Customer Stickiness: Products are embedded as mission-critical tools in customer workflows, leading to a high renewal rate of 93% across the portfolio as of Q3 2025. The Academia & Government segment specifically achieved a 96% renewal rate.
- Scale and Global Reach: Serve over 4,800 institutions with AI tools and maintain a global footprint that provides deep market access and allows for the standardization of research and IP processes worldwide.
- AI-Driven IP Growth: The Intellectual Property segment is well-positioned to benefit from AI innovation trends, seeing a return to growth driven by a surge in AI-related patent filings that require their specialized search tools.
For a deeper dive into the numbers driving these operations, you should read Breaking Down Clarivate Plc (CLVT) Financial Health: Key Insights for Investors.
Clarivate Plc (CLVT) How It Makes Money
Clarivate Plc makes money by providing mission-critical data, analytics, and workflow solutions, primarily through a subscription-based model to customers in the academic, government, life sciences, and intellectual property sectors. The core of its financial engine is the highly predictable, recurring revenue from long-term contracts for access to its proprietary content and software platforms, like Web of Science and Derwent.
Clarivate Plc's Revenue Breakdown
The company is intentionally shifting its business model to prioritize subscription and re-occurring revenue (like patent renewals) over transactional sales, a key part of its Value Creation Plan. The following breakdown uses the most recent data from the third quarter of 2025, which reflects this strategic pivot.
| Revenue Stream | % of Total (Q3 2025) | Growth Trend (Organic) |
|---|---|---|
| Subscription Revenue | 65.1% | Increasing (up 1.2%) |
| Re-occurring Revenue (e.g., Patent Renewals) | 16.9% | Decreasing (down 3.2%) |
| Transactional Revenue | 18.0% | Strategic Decline (down 2.3% organically in Q1 2025, volatile) |
Business Economics
You should view Clarivate Plc as a subscription business (SaaS) with a high degree of revenue visibility, plus a significant intellectual property (IP) services component. The real value is locked in the sticky, proprietary data sets and the integrated workflow solutions that make it hard for customers to switch providers.
- High Renewal Rates: The company's overall renewal rate has improved to a robust 93% as of the third quarter of 2025, which is defintely a marker of essential, non-discretionary products.
- Annual Contract Value (ACV) Growth: Organic ACV, which tracks the value of new and renewed contracts, grew 1.6% year-over-year in Q3 2025. This shows they are not just retaining customers but also successfully upselling or increasing prices.
- Subscription-First Pricing: Clarivate is actively converting legacy transactional products, especially in the Academia & Government (A&G) segment, into subscription-based offerings. For instance, the A&G segment's subscription revenue now constitutes approximately 93% of that segment's total revenue.
- AI-Driven Efficiencies: The company is investing in AI-led product innovation to enhance its offerings and operational efficiency, aiming to accelerate growth and reduce complexity.
Here's the quick math: with 88% of organic revenue being recurring through the first nine months of 2025, the business has a strong, predictable base that acts as a buffer against market volatility. You can learn more about the institutional interest in the company here: Exploring Clarivate Plc (CLVT) Investor Profile: Who's Buying and Why?
Clarivate Plc's Financial Performance
The company's full-year 2025 guidance, updated in October 2025, reflects the benefits of its strategic focus on higher-margin recurring revenue, even as it navigates the impact of strategic divestitures (portfolio rationalization) that reduce total reported revenue. This is a classic move to trade short-term top-line scale for long-term margin and quality of earnings.
- Full-Year Revenue: Clarivate Plc raised its full-year 2025 revenue outlook to a range of $2.42 billion to $2.45 billion, up from its previous guidance, largely due to better-than-expected transactional book sales and favorable currency exchange rates.
- Adjusted EBITDA and Margin: The full-year 2025 Adjusted EBITDA guidance is maintained in the range of $940 million to $1.00 billion. This translates to an expected Adjusted EBITDA Margin of approximately 41% for the full year, a clear sign of the high operating leverage inherent in the data and software business model.
- Free Cash Flow (FCF): The company expects to generate approximately $340 million in Free Cash Flow at the midpoint of its 2025 guidance. This strong cash generation is crucial, as it allows for both debt reduction-they repaid $100 million of debt in Q3 2025-and shareholder returns, with approximately $150 million used for share repurchases year-to-date through Q3 2025.
- Debt Management: Total debt outstanding as of September 30, 2025, was approximately $4.47 billion, a focus area for management, which is using FCF to deleverage.
Clarivate Plc (CLVT) Market Position & Future Outlook
Clarivate Plc is navigating a complex transition, shifting its business model aggressively toward a higher-margin, subscription-first revenue mix, which is key to stabilizing its future. The company is on track to deliver full-year 2025 revenue between $2.42 billion and $2.45 billion, a revised outlook that reflects improved transactional book sales and favorable currency effects.
Competitive Landscape
In the world of research intelligence and intellectual property (IP) data, Clarivate competes with giants who have vast resources and deep market penetration. You need to see this not as a single market, but as a three-front war: Academia, IP, and Life Sciences. Here's how the landscape looks as of late 2025, focusing on their core strengths.
| Company | Market Share, % (Est.) | Key Advantage |
|---|---|---|
| Clarivate Plc | 10-15% | Gold-standard, editorially-curated IP and citation data (Derwent, Web of Science). |
| RELX (Elsevier) | 35-45% | Dominant position in academic publishing and research workflow (Scopus, ScienceDirect). |
| IQVIA Holdings Inc. | 15-20% | Unmatched scale in real-world data (RWD) for Life Sciences and clinical trials. |
Opportunities & Challenges
The company's Value Creation Plan is the roadmap, aiming to increase the organic recurring revenue mix, which already improved 800 basis points to 88% through the first nine months of 2025. But that shift isn't simple; it creates friction. You can read a deeper dive on the underlying financial health here: Breaking Down Clarivate Plc (CLVT) Financial Health: Key Insights for Investors.
| Opportunities | Risks |
|---|---|
| Accelerated AI Integration across all segments (Derwent, Cortellis). | Execution risk in transitioning transactional products to subscription-only models. |
| Expanding the mix of organic recurring revenue to enhance predictability. | Macroeconomic volatility and a slowdown in global R&D spending. |
| Portfolio rationalization through divestitures to focus on core, high-margin assets. | Pressure on university/government budgets, impacting the Academia & Government segment. |
| Organic Annual Contract Value (ACV) growth rate accelerating to 1.6% in Q3 2025. | High debt load and cash interest payments limiting growth investment flexibility. |
Industry Position
Clarivate is a critical, mid-tier player in the transformative intelligence market, positioned as the neutral, editorially-independent data provider, especially in the Intellectual Property and Academia & Government sectors. The core strength is its proprietary, high-quality data assets like the Web of Science and Derwent patent data, which are mission-critical for researchers and IP professionals globally. They simply can't be easily replicated.
The company's full-year 2025 Adjusted EPS guidance of $0.60 to $0.70 suggests a focus on profitability and operational efficiency, driven by cost management and the Value Creation Plan. The market is watching the organic growth rate; while organic subscription revenue saw a 1.2% growth in Q3 2025, the overall organic revenue was essentially flat, indicating the drag from planned transactional revenue wind-downs.
- Capital Allocation: Management is actively repurchasing shares (11.7 million in Q3 2025) and repaying debt ($100 million in Q3 2025), signaling confidence in future cash flow.
- Cash Generation: Expecting approximately $340 million in free cash flow for the full year 2025, providing capital for AI investment and deleveraging.
- Strategic Focus: The push to embed agentic AI across platforms is the defintely most important strategic lever for the next 12-18 months, aiming for product-led recurring revenue growth.
The next action item for any investor is to track the organic recurring revenue growth rate quarter-over-quarter; it needs to consistently accelerate above the current low-single-digit rate to justify the long-term value creation narrative.

Clarivate Plc (CLVT) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.